Sat, Jan 31, 2015, 6:19 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Ampio Pharmaceuticals, Inc. Message Board

racavalli 21 posts  |  Last Activity: Jan 27, 2015 2:29 PM Member since: Jul 31, 2012
  • This article is such obvious trash and lies that Ampio shares will not be affected because nobody is that stupid to fall for it except the writer and Seeking Alpha.

    Very clumsy attempt by a very bad writer.

    Sentiment: Strong Buy

  • Shares almost always make very large moves before news hits.

    Sellers are exhausted. Shorts are many and nervous. News on Optina could hit any day and it is most likely going to be very positive because the company already told everybody they would only tell shareholders the Optina results if they were bad.

    Ampion is deep into trials and the company could easily surprise.

    We have been repeatedly told that the company is in discussions with big pharma. With the kind of data we have already seen from the safety 7, it would not be a surprise to hear news abut a major licensing deal going down in the next month or two . . . or????

    Meanwhile, enjoy the show.

    I am sticking with my earlier projections of triple digits by the end of 2015 because I am confident it will be demonstrated that Ampion does in fact regenerate cartilage. THERE IS NO OTHER POSSIBLE EXPLANATION FOR THE OVER 90% PAIN REDUCTION 5 MONTHS AFTER THE INJECTIONS. This has never been done before and clearly the value will be unpredictably enormous.

    Again, enjoy a wonderful show for 2015.

    P.S.
    It is highly likely that Fraudstein will try to derail shares when his hedge fund bosses pay him to write another hit article, but he has already lost credibility with AMPE traders and shareholders. Use his articles as a buying opportunity!

    Sentiment: Strong Buy

  • racavalli racavalli Jan 23, 2015 8:18 PM Flag

    Not really. Hedge funds short in large numbers of shares and are in and out in the blink of an eye.

    As the price and volume rises, watch the short position increase as older shorts cover and new shorts establish positions.

    Shorts are actually positive by increasing liquidity.

    They will be overpowered by the big buying as volume swells with big news in the coming months.

    Sentiment: Strong Buy

  • Reply to

    Billoney vs. Facts vs. Optina, who wins?

    by ri66 Jan 22, 2015 9:58 AM
    racavalli racavalli Jan 22, 2015 12:31 PM Flag

    If a reader looks at the mechanism by which Optina works that was clearly explained in Retina Today (Optina actually repairs the F-Actin cortical ring Structure of the cells comprising the linings of the blood vessels) and then reads the simple explanation as to why the trial was halted early . . . and then considers what the company stated in December that they would only release the Optina results if they were bad.. then the reader would quickly call their broker and load up before the explosion. And that does not include any discussion about Ampion.

    I hope hedge funds continue to suppress shares with short selling.

    Sentiment: Strong Buy

  • No news is good news for many reasons. Especially with buying becoming more aggressive.

    We are now in a window of time where AMPE will likely be reporting DAZZLING NEWS.

    This is going to be a fun show especially for all those long-term investors who have made the commitment to ride out the tough times.

    I couldn't help but notice that the message boards are unusually quiet when shares are up on increasing volume.

    Most will call me crazy but I'm sticking with my predictions that AMPE will be a triple digit stock before the end of 2015.

    Sentiment: Strong Buy

  • Get ready for the December quarter results in the next month. They will very likely be even bigger.

    Their model is very simple to understand and they have already implemented enough tests in enough offices to generate HUGE revenues.

    An analysis of the business model indicates that these diagnostics pay for themselves within the first month or two and then become exceptionally profitable thereafter and the growth rate is staggering.

    Everybody has an opinion and certainly has the right to express it, but anybody trying to discredit this company does not know what they are talking about and readers should be very skeptical of these naysayers that will wind up costing fortunes in missed opportunity.

    Sentiment: Strong Buy

  • Reply to

    Playing out exactly as I predicted

    by billf153 Dec 17, 2014 4:06 PM
    racavalli racavalli Dec 18, 2014 12:29 PM Flag

    Large receivables will be flowing in.

    Cash may be tight now, but not for long.

    Shares are remarkably cheap and this is almost the end of tax selling.

    Sentiment: Strong Buy

  • racavalli by racavalli Dec 9, 2014 8:56 AM Flag

    Macaluso said the company would not release the Optina results before the meeting with the FDA which was expected to be in January because of the holidays getting in the way.

    He said, however, that they would release the results to shareholders before the FDA meeting if they were bad.

    We have heard nothing about Optina.

    Does this mean results are positive?

    Sentiment: Strong Buy

  • Reply to

    Listen People

    by gornakhikyan Dec 4, 2014 3:53 PM
    racavalli racavalli Dec 4, 2014 7:42 PM Flag

    You are correct that with sales this strong and knowing that receivables will come in because these diagnostics are reimbursed by Medicare and insurance, funding growth will not be difficult.

    This is one of the least risky stocks I know of with big growth potential because the model and the diagnostics and the sales are already in place. it just gets better with time.

    Sentiment: Strong Buy

  • I would love to be holding a bag full of MHCC shares. When you run the numbers of their projections, and when you compare the September quarter ACTUAL RESULTS, it is clear that this bag full of shares will be worth more than gold in 2015 and beyond.

    Sentiment: Strong Buy

  • Today's call stated that the current quarter ending December 31st is also very strong.

    Management aso mentioned that the big sales increases were from two diagnostics and that they will be adding DermCDx in January and are predicting they expect to have a total of 6 diagnostics by the end of next year.

    With 1,300 offices signed up and the rollout JUST BEGINNING, Millennium looks poised for exponential growth that is going to make today's buyers very wealthy if they commit and buy and just sock shares away.

    Remember, these sale are not just a one time event. they will continue to grow exponentially as the number of physician offices and the number of diagnostics increases. The numbers will be staggering.

    I would not be tempted to sell shares for several years because this kind of growth is very rare and almost impossible to find on Wall Street.

    Between the 10Q filing with the SEC and today's call, it is very clear that Millennium HealthCare is very much FOR REAL!

    We are fortunate to have such a brilliant and dedicated management team.

    Beware of naysayers trying to discredit Millennium and team. They are wrong and will cost you a lot of money in lost opportunity if you listen to them.

    Sentiment: Strong Buy

  • Reply to

    Just sold all my shorts.

    by billwiiliams836 Dec 1, 2014 1:21 PM
    racavalli racavalli Dec 1, 2014 1:30 PM Flag

    What planet are you from?

    You don't sell your shorts to cover. YOU BUY TO COVER! You should learn the correct trading terminology before you post ridiculous comments like that.

    Interesting that you admit being short when all the time you were talking out of both sides of your mouth just like most people thought.

    Sentiment: Strong Buy

  • racavalli racavalli Nov 29, 2014 9:08 PM Flag

    There is nothing "SCAM" about filing a 10Q with the SEC that clearly demonstrates a revenue increase of over 1200%.

    You are either trying to buy shares cheap or can't read.

    Sentiment: Strong Buy

  • Reply to

    Short interest is now 10,344,900

    by naples4sun Nov 26, 2014 9:03 AM
    racavalli racavalli Nov 26, 2014 11:41 AM Flag

    Thank you very sincerely for your kind thoughts.

    I've been quite busy talking about a few other companies that have equally exciting stories as Ampio.

    Happy Thanksgiving, Happy Holidays and Merry Christmas . . . but most of all . . . stay healthy and happy.

    And get ready for a show by AMPE that nobody is going to believe. the stage is set, and the time is within weeks or months.

    :-)

    Sentiment: Strong Buy

  • Reply to

    Short interest is now 10,344,900

    by naples4sun Nov 26, 2014 9:03 AM
    racavalli racavalli Nov 26, 2014 9:27 AM Flag

    Add in the January Effect!

    Sentiment: Strong Buy

  • The 10Q shows large receivable that are due from diagnostic revenues.

    It probably takes at least 60 days from billing t receive funds which means that MHCC is about to begin to see arge revenues rolling in and doing nothing but growing and growing sharply from here.

    Sentiment: Strong Buy

  • Reply to

    Q3 report opinion

    by katherine.delafontaine Nov 17, 2014 8:34 AM
    racavalli racavalli Nov 17, 2014 9:50 AM Flag

    Based on the overall picture, I do not believe the large number of shares issued will have any meaningful impact on the future performance of MHCC shares in the marketplace because the staggering sales projections (which have just been validated by the the 10Q filing last week) validate the projections and expectations for a very high priced stock in the coming years.

    I also believe that the more shares and options held by management, the better it is for price performance in the future as management will be highly motivated to strive for the best results. I like to see management owning as many shares and options as possible.

    Management has been exceptionally creative in developing this unique business model and executing with little cash.

    I strongly recommend buying and holding for the long term for big maximum benefit. I believe the growth can and will be spectacular.

    Sentiment: Strong Buy

  • Management reported in detail.

    The most significant detail is the revenues which were spectacular.

    There were countless details accounted for and many details provided about shares that were paid out to consultants, etc and that is certainly not unusual for an early stage company to pay certain costly expenses with stock.

    When revenue and profit potential is weighed, these stock issuances look insignificant compared to the overall picture. These revenues were based on a very small number of physician's offices and when we realize the growth potential, it is staggering.

    With explosive revenues actually materializing exactly as the company has been projecting, attracting capital will not be difficult.

    MHCC is a much safer buy now and is very attractive for the long term.

    Sentiment: Strong Buy

  • racavalli racavalli Nov 12, 2014 2:25 PM Flag

    Millennium is positioned to report spectacular revenues for the Sep quarter and for several years to come.

    Their margins are very high and should create equally spectacular earnings in the future.

    I would expect earnings on huge sales to lag for the next few quarters as the company ramps up.

    Shares at these levels represent an outstanding buying opportunity

    Sentiment: Strong Buy

  • Reply to

    Prevent AMPE from being sold short

    by skulik007 Oct 31, 2014 3:13 PM
    racavalli racavalli Nov 4, 2014 10:26 AM Flag

    check with your broker.

    shares held even in a cash account are normally vested in "Street Name" meaning the brokerage firm can lend them out for a fee.

    besides . . . once again . . . short sellers are typically positioned for only short periods of time and can easily sell naked. they don't always need to borrow shares.

AMPE
5.02-0.22(-4.20%)Jan 30 4:05 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Hawaiian Holdings Inc.
NASDAQFri, Jan 30, 2015 4:00 PM EST
Visa Inc.
NYSEFri, Jan 30, 2015 4:00 PM EST
Breitburn Energy Partners L.P.
NASDAQFri, Jan 30, 2015 4:00 PM EST